The post-pandemic demands brought a critical shift in varied industry verticals, most notably the pharmaceutical sector. Increased focus on health with new therapeutic modalities and geopolitics is motivating this transformation while curbing manpower dependencies. These changes are witnessed as decentralized trials, digital patient engagement tools, revival of wearable devices continue to drive impactful automation across key facets in the industry.
Fueling this transformative journey is the Research and Development (R&D) sector, tirelessly working to turn cutting-edge clinical solutions into reality through an array of clinical trials. In the pursuit of continuity and quality in medical supply chains, R&D is expanding its digital footprint through the adoption of e-clinical trial management solutions. These offerings have become game-changers for their ability to optimize analytics and edge computing, provide real-time transparencies, and enable faster and more accurate results generation.
By leveraging machine learning algorithms, e-clinical trial management platforms autonomously analyze vast datasets, significantly expediting the identification of potential drug candidates and expediting the trial process. This innovative approach not only reduces costs but enhances the accuracy of results, marking a significant milestone in the pharmaceutical industry’s pursuit of efficiency. Above all, virtual trials are streamlining medical procedures and reducing production downtime, empowering trial runners and sponsors to usher in an era of novel therapies.
This edition of Pharma Tech Outlook presents a forward-looking list of e-clinical trial management solutions providers. It grasps on thoughtful insights from Haichen Yang, vice president of clinical research at Amicus Therapeutics Inc, Tony Johnson, senior director of global clinical quality assurance at Mallinckrodt Pharmaceuticals, and Safwan Kezbor, senior medical director of clinical development at Shionogi. The edition also leans into inventive research and developments from Credent Partners, a U.S. based company enhancing trial management for med-tech start-ups.
